RenovoRx, Inc. ( RNXT) - Key Metrics
RNXT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.02 | -$0.06 | -$0.06 | -$0.06 |
| 2026Q1 | $0.01 | -$0.09 | -$0.10 | -$0.10 |
| 2025Q4 | $0.01 | -$0.08 | -$0.09 | -$0.09 |
| 2025Q3 | $0.01 | -$0.08 | -$0.06 | -$0.06 |
| 2025Q2 | $0.01 | -$0.08 | -$0.06 | -$0.06 |
RNXT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.08 |
| 2026Q1 | 0% | -2.73 |
| 2025Q4 | 0% | -2.51 |
| 2025Q3 | 0% | -3.97 |
| 2025Q2 | 0% | -4.17 |
RNXT
Price: $1.20
52 week price:
Earnings Per Share: -0.27 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 20500
Market Capitalization: 66.2 million